O. Finney

发表

Distinct Roles for FOXP3+ and FOXP3− CD4+ T Cells in Regulating Cellular Immunity to Uncomplicated and Severe Plasmodium falciparum Malaria

D. Conway, E. Riley, Ian H Cheeseman, 2009, PLoS pathogens.

Natural killer cells and innate immunity to protozoan pathogens.

E. Riley, O. Finney, D. Korbel, 2004, International journal for parasitology.

Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy

R. Hevner, G. Ishak, M. Jensen, 2019, Annals of neurology.

Preemptive Mitigation of CD19 CAR T Cell Cytokine Release Syndrome Without Attenuation of Anti-Leukemic Efficacy.

M. Jensen, A. Taraseviciute, Francesco Ceppi, 2019, Blood.

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.

S. Riddell, K. Kelly-Spratt, A. Oron, 2017, Blood.

Acquisition of a CD 19-negative myeloid phenotype allows immune escape of MLL-rearranged BALL from CD 19 CART-cell therapy

D. Maloney, David Wu, C. Turtle, 2016 .

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.

D. Maloney, David Wu, C. Turtle, 2016, Blood.

Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility

M. Jensen, A. Taraseviciute, O. Finney, 2016, Clinical Cancer Research.

Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion.

M. Jensen, A. Taraseviciute, O. Finney, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Manufacture of CAR-T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion.

M. Jensen, A. Taraseviciute, O. Finney, 2018 .

Predicting Antidisease Immunity Using Proteome Arrays and Sera from Children Naturally Exposed to Malaria*

M. Vignali, M. Gardner, P. Siba, 2014, Molecular & Cellular Proteomics.

Decreased Rates of Severe CRS Seen with Early Intervention Strategies for CD19 CAR-T Cell Toxicity Management

A. Oron, M. Jensen, O. Finney, 2016 .

Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia

M. Jensen, Lauren A Huang, O. Finney, 2018, Blood.

Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.

J. Kublin, K. Stuart, S. Kappe, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Distinct Roles for FOXP 3 + and FOXP 3 2 CD 4 + T Cells in Regulating Cellular Immunity to Uncomplicated and Severe Plasmodium falciparum Malaria

D. Conway, E. Riley, E. Lawrence, 2017 .

CD19 CAR T cell product and disease attributes predict leukemia remission durability.

R. Orentas, M. Jensen, O. Finney, 2019, The Journal of clinical investigation.

Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates.

H. D. Liggitt, S. Furlan, C. Turtle, 2018, Cancer discovery.

Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses.

M. Gardner, D. Molina, P. Felgner, 2012, The American journal of tropical medicine and hygiene.

Regulatory T cells in malaria--friend or foe?

E. Riley, M. Walther, O. Finney, 2010, Trends in immunology.

Phenotypic analysis of human peripheral blood regulatory T cells (CD4+FOXP3+CD127lo/–) ex vivo and after in vitro restimulation with malaria antigens

E. Riley, M. Walther, O. Finney, 2009, European journal of immunology.

Homeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission

D. Conway, E. Riley, D. Nwakanma, 2009, European journal of immunology.

P. falciparum Enhances HIV Replication in an Experimental Malaria Challenge System

R. Schooley, F. Vaida, S. Kappe, 2012, PloS one.

Title: Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Non-Human Primates

H. D. Liggitt, S. Furlan, S. Riddell, 2018 .

Updated Clinical and Correlative Results from the Phase I CRB-402 Study of the BCMA-Targeted CAR T Cell Therapy bb21217 in Patients with Relapsed and Refractory Multiple Myeloma

S. Jagannath, A. Jakubowiak, D. Siegel, 2021, Blood.

Freeze-thaw lysates of Plasmodium falciparum-infected red blood cells induce differentiation of functionally competent regulatory T cells from memory T cells

E. Riley, E. Lawrence, M. Walther, 2012, European journal of immunology.

Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge

J. Kublin, S. Kappe, P. Gilbert, 2014, PloS one.

Effects of Prior Alkylating Therapies on Preinfusion Patient Characteristics and Starting Material for CAR T Cell Product Manufacturing in Late-Line Multiple Myeloma

Afshin Mashadi-Hossein, H. Bitter, Ronald J. Hause, 2020 .

Baseline Correlates of Complete Response to Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy in Patients with Relapsed and Refractory Multiple Myeloma: Subanalysis of the KarMMa Trial

S. Jagannath, N. Munshi, A. Agarwal, 2021, Blood.

First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.

S. Kappe, A. Cowman, P. de la Vega, 2013, Vaccine.

T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse

K. Kelly-Spratt, A. Oron, M. Jensen, 2014 .

Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites.

S. Kappe, A. Kaushansky, Ruobing Wang, 2014, Vaccine.

Prolonged functional persistence of CD19CAR t cell products of defined CD4:CD8 composition and transgene expression determines durability of MRD-negative ALL remission.

A. Oron, M. Jensen, O. Finney, 2016 .

Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial

D. Siegel, M. Liedtke, F. Petrocca, 2023, Nature Medicine.

CD19 CAR T cell product and disease attributes predict leukemia remission durability.

R. Orentas, M. Jensen, O. Finney, 2019, The Journal of clinical investigation.

Distinct Roles for FOXP3+ and FOXP3− CD4+ T Cells in Regulating Cellular Immunity to Uncomplicated and Severe Plasmodium falciparum Malaria

D. Conway, E. Riley, E. Lawrence, 2009, PLoS pathogens.

Phenotypic analysis of human peripheral blood regulatory T cells (CD4+FOXP3+CD127lo/–) ex vivo and after in vitro restimulation with malaria antigens

E. Riley, M. Walther, O. Finney, 2009, European Journal of Immunology.